Ireland - English - HPRA (Health Products Regulatory Authority)

baxter healthcare limited - retinol palmitate; colecalciferol; dl-alfa tocoferol; ascorbic acid; pyridoxine hydrochloride; cyanocobalamin; folic acid; dexpanthenol; biotin; nicotinamide; cocarboxylase tetrahydrate; riboflavin sodium phosphate - powder for solution for injection/infusion - n/a - multivitamins, plain

Ireland - English - HPRA (Health Products Regulatory Authority)

baxter healthcare limited - retinol palmitate colecalciferol dl-alfa-tocoferol ascorbic acid cocarboxylase tetrahydrate riboflavin sodium phosphate pyridoxine hydrochloride cyanocobalamin folic acid dexpanthenol biotin nicotinamide - pdr for soln inj/inf - %v/v

Israel - English - Ministry of Health

remedix care ltd - ascorbic acid; biotin; cocarboxylase tetrahydrate; colecalciferol; cyanocobalamin; dexpanthenol; folic acid; nicotinamide; pyridoxine (vit b6) hydrochloride; retinol palmitate; riboflavine; tocopherol - powder for solution for injection - retinol palmitate 3500 iu/vial; colecalciferol 220 iu/vial; tocopherol 10.2 mg/vial; ascorbic acid 125 mg/vial; riboflavine 5.67 mg/vial; pyridoxine (vit b6) hydrochloride 5.5 mg/vial; cyanocobalamin 0.006 mg/vial; folic acid 0.414 mg/vial; dexpanthenol 16.15 mg/vial; biotin 0.069 mg/vial; nicotinamide 46 mg/vial; cocarboxylase tetrahydrate 5.8 mg/vial - combinations - combinations - vitamin supplementation in patients receiving parenteral nutrition. only for adults and children over 11 years of age.

Ireland - English - HPRA (Health Products Regulatory Authority)

baxter holding b.v. - retinol palmitate; cholecalciferol; dl-a-tocopherol; ascorbic acid; cocarboxylase tetrahydrate; riboflavin sodium phosphate; pyridoxine hydrochloride ; cyanocobalamin; folic acid; dexpanthenol; d-biotin; nicotinamide - powder for solution for injection/infusion - multivitamins, plain

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - riboflavine sodium phosphate, quantity: 5.67 mg; pyridoxine hydrochloride, quantity: 5.5 mg; cyanocobalamin, quantity: 6 microgram; nicotinamide, quantity: 46 mg; dl-alpha-tocopherol, quantity: 10.2 mg; ascorbic acid, quantity: 125 mg; retinol palmitate, quantity: 3500 iu; colecalciferol, quantity: 5.5 microgram; dexpanthenol, quantity: 16.15 mg; biotin, quantity: 69 microgram; cocarboxylase tetrahydrate, quantity: 5.8 mg (equivalent: thiamine, qty 3.51 mg); folic acid, quantity: 414 microgram - injection, powder for - excipient ingredients: glycine; glycocholic acid; hydrochloric acid; sodium hydroxide; lecithin - cernevit is indicated in adults and children over 11 years of age requiring parenteral multivitamin supplementation to correct or prevent vitamin deficiencies when oral administration is contraindicated, impossible or insufficient. the product does not contain vitamin k, which may be given separately if required.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ceva animal health pty ltd - riboflavin-5-phosphate sodium - unknown - riboflavin-5-phosphate sodium vitamin-b2 active 0.0 - active constituent

Israel - English - Ministry of Health

remedix care ltd - ascorbic acid; biotin; cocarboxylase tetrahydrate; colecalciferol; cyanocobalamin; dexpanthenol; folic acid; nicotinamide; pyridoxine (vit b6) hydrochloride; retinol palmitate; riboflavine; tocopherol - powder for solution for injection - retinol palmitate 3500 iu/vial; colecalciferol 220 iu/vial; tocopherol 10.2 mg/vial; ascorbic acid 125 mg/vial; riboflavine 5.67 mg/vial; pyridoxine (vit b6) hydrochloride 5.5 mg/vial; cyanocobalamin 0.006 mg/vial; folic acid 0.414 mg/vial; dexpanthenol 16.15 mg/vial; biotin 0.069 mg/vial; nicotinamide 46 mg/vial; cocarboxylase tetrahydrate 5.8 mg/vial - combinations - vitamin supplementation in patients receiving parenteral nutrition. only for adults and children over 11 years of age.

United States - English - NLM (National Library of Medicine)

raw materials international overseas llc - riboflavin 5'-phosphate sodium (unii: 20rd1dzh99) (riboflavin - unii:tlm2976ofr), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), dexpanthenol (unii: 1o6c93ri7z) (dexpanthenol - unii:1o6c93ri7z), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4), thiamine hydrochloride (unii: m572600e5p) (thiamine ion - unii:4abt0j945j) - riboflavin 2 mg in 1 ml - in disorders requiring parenteral administration of vitamins, i.e. pre- and post-operative treatment, when requirements are increased as in fever, severe burns, increased metabolism, pregnancy, gastrointestinal disorders interfering with intake or absorption of vitamins, prolonged or wasting diseases, alcoholism and where other deficiencies exist. sensitivity to the ingredients listed.

United States - English - NLM (National Library of Medicine)

hospira, inc. - retinol (unii: g2sh0xkk91) (retinol - unii:g2sh0xkk91), ergocalciferol (unii: vs041h42xc) (ergocalciferol - unii:vs041h42xc), .alpha.-tocopherol acetate, dl- (unii: wr1wpi7ew8) (.alpha.-tocopherol, dl- - unii:7qwa1rio01), phytonadione (unii: a034se7857) (phytonadione - unii:a034se7857), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4), riboflavin 5'-phosphate sodium (unii: 20rd1dzh99) (flavin mononucleotide - unii:7n464 - retinol 1 mg in 5 ml - m.v.i. adult™ is a combination of vitamins indicated for the prevention of vitamin deficiency in adults and pediatric patients aged 11 years and above receiving parenteral nutrition. the physician should not await the development of clinical signs of vitamin deficiency before initiating vitamin therapy. m.v.i. adult is contraindicated in patients who have: risk summary administration of the approved recommended dose of m.v.i. adult in parenteral nutrition is not expected to cause major birth defects, miscarriage, or adverse maternal or fetal outcomes. pregnant women should follow the u.s. recommended daily allowances for pregnancy because their vitamin requirements may exceed those of nonpregnant women. deficiency of essential vitamins may result in adverse pregnancy outcomes (see clinical considerations) . animal reproduction studies have not been conducted with m.v.i. adult administered by intravenous infusion. the estimated background risk of major birth defects and miscarriage for the indicated population

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

kyorin rimedio co.,ltd. - riboflavin butyrate - orange yellow tablet, diameter : 8.1 mm, thickness : 3.0 mm